In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 6th, 2004 | 26 | Yes |
Popular Name: Levomethadyl Acetate Levomethadyl Acetate
Find On: PubMed — Wikipedia — Google
CAS Numbers: 1477-40-3 , 43033-72-3 , 509-74-0
(-)-6-(Dimethylamino)-4,4-diphenyl-3-heptanol acetate (ester)
(1S,4S)-4-(dimethylamino)-1-ethyl-2,2-diphenylpentyl acetate
(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-2-yl acetate
1477-40-3; C08012; LAAM; Levomethadyl acetate
3-HEPTANOL, 6-(DIMETHYLAMINO)-4,4-DIPHENYL-, ACETATE (ester), (3S,6S)-(-)-
3-Heptanol, 6-(dimethylamino)-4,4-diphenyl-, acetate (ester), (3S,6S)-(-)- (8CI)
43033-72-3; D00840; Levomethadyl acetate hydrochloride (USAN); Orlaam (TN)
509-74-0; Acetylmethadol (INN); D04973; Methadyl acetate (USAN)
Benzeneethanol, beta-(2-(dimethylamino)propyl)-alpha-ethyl-beta-phenyl-, acetate (ester), (-)-
Levacetilmetadol [INN-Spanish]
levacetilmetadol; levacetylmethadol; levacetylmethadolum
Levacetylmethadol (INN); Levomethadyl Acetate (USAN); Levomethadyl Acetate HCl (FDA
Levacetylmethadolum [INN-Latin]
Levomethadyl Acetate Hydrochloride
Levomethadyl Acetate Hydrochloride (FDA
USAN); Levacetylmethadol (INN); Levomethadyl Acetate (USAN)
[(3S,6S)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate
[S-(R*,R*)]-beta-[2-Dimethylamino)propyl]-alpha-ethyl-beta-phenylbenzeneethanol acetate (ester)
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 5.14 | 5.4 | -30.54 | 1 | 3 | 1 | 30 | 354.514 | 9 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 1.79e-03 g/l | DrugBank-approved |
PUBCHEM_PATENT_ID | EP0174342A1; EP1040829A3; EP1051181A2; EP1054998A1; US4771059; US4933438; US5082853; US5296483; US5795909; US5834480; US5919473; US5985856; WO1985003937A1; WO1997044063A2; WO1998051246A1; WO1998056382A1; WO1999033846A2; WO1999036570A2; WO2000040604A2; WO2 | IBM Patent Data |
Patent Database Links | EP1584335; US2005026963; US2005065340; US2005085514; US2005153986; US2005240021; US2006154929; US2006193926; US2007213338; US2008234306; WO2005041971; WO2006127898; WO2006127899; WO2008136865 | ChEBI |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD-1-E | Delta Opioid Receptor (cluster #1 Of 3), Eukaryotic | Eukaryotes | 450 | 0.34 | Binding ≤ 10μM |
OPRK-3-E | Kappa Opioid Receptor (cluster #3 Of 6), Eukaryotic | Eukaryotes | 450 | 0.34 | Binding ≤ 10μM |
OPRM-1-E | Mu-type Opioid Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 450 | 0.34 | Binding ≤ 10μM |
SGMR1-1-E | Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic | Eukaryotes | 450 | 0.34 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
OPRD_RAT | P33533 | Delta Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 1μM |
OPRK_RAT | P34975 | Kappa Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 1μM |
OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 1μM |
SGMR1_RAT | Q9R0C9 | Sigma Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 1μM |
OPRD_RAT | P33533 | Delta Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 10μM |
OPRK_RAT | P34975 | Kappa Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 10μM |
OPRM_RAT | P33535 | Mu Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 10μM |
SGMR1_RAT | Q9R0C9 | Sigma Opioid Receptor, Rat | 1.2 | 0.48 | Binding ≤ 10μM |
Description | Species |
---|---|
G alpha (i) signalling events | |
G-protein activation | |
Opioid Signalling | |
Peptide ligand-binding receptors |